| Dr Karen Sue Wagenhals, MD | |
|
335 Glessner Ave, Mansfield, OH 44903-2269 | |
| (419) 526-8486 | |
| Not Available |
| Full Name | Dr Karen Sue Wagenhals |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 335 Glessner Ave, Mansfield, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952491870 | NPI | - | NPPES |
| 2289161 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35-041504 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Sue Wagenhals, MD 335 Glessner Ave, Mansfield, OH 44903-2269 Ph: (419) 526-8486 | Dr Karen Sue Wagenhals, MD 335 Glessner Ave, Mansfield, OH 44903-2269 Ph: (419) 526-8486 |
News Archive
Worldwide, more than three million children die each year on the day they are born - either during birth or shortly afterwards. If their mothers had received acceptable care during childbirth, almost all of these children would be alive, fit and healthy.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
An article published in the September issue of BioScience highlights the challenges facing biological societies and offers insights for scientific societies to respond and adapt to the changing dynamics of 21st century science.
Fluidigm Corporation today announced the release of its amplicon tagging protocol for the Illumina GA II next-generation sequencer. The 48.48 Access Array integrated fluidic circuit (IFC) allows Illumina GA II users to automatically prepare sequencing-ready libraries from 48 individual samples at a time, for as little as $7 (U.S.) per sample.
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
› Verified 2 days ago
Dr. Ian Craig Talbott, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave # 1370, Mansfield, OH 44903 Phone: 419-526-8486 | |
John Howard Burgess, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8000 Fax: 418-520-2846 | |
Jonathan Simon Fain, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Pathology Department, Mansfield, OH 44903 Phone: 419-526-8509 Fax: 419-520-2846 | |
Dr. Homer O Wiland Iv, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 330-718-1740 |